TrialAnnals of the rheumatic diseases2013
Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients.
Ronald F van Vollenhoven et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
147 papers cite itlatest 60 shown
this paperpooled ittrialcites it